First, the level of PSA is susceptible to several interference factors, such as benign prostatic hyperplasia (BPH) and prostatitis, which can both increase the PSA concentration and lead to unnecessary intervention in noncancer patients. The gene discussed is KLK3; the disease is prostatitis.